FIGS Stock Recent News

FIGS, Inc.'s earnings show mixed results, with strong international growth but declining U.S. sales and weak FY25 guidance, raising concerns about profitability and customer acquisition. Despite strong product innovation, FIGS struggles with high marketing costs, poor customer acquisition, and stagnating U.S. sales, making its high valuation unjustifiable. International expansion is promising but comes with lower margins; new management might improve execution, but significant challenges remain.

Although the revenue and EPS for Figs (FIGS) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

FIGS, Inc. (NYSE:FIGS ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Tom Shaw - Senior Vice President, Investor Relations Trina Spear - Co-Founder & Chief Executive Officer Sarah Oughtred - Chief Financial Officer Conference Call Participants Brooke Roach - Goldman Sachs Brian Nagel - Oppenheimer John Kernan - TD Cowen Dana Telsey - Telsey Group Lorraine Hutchinson - Bank of America Matt Koranda - ROTH Capital Ashley Owens - KeyBanc Capital Markets Nathan Feather - Morgan Stanley Operator Good afternoon, everyone, and thank you for joining today's FIGS Fourth Quarter Fiscal 2024 Earnings Conference Call. My name is Reagan, and I'll be your moderator today.

Figs (FIGS) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.05 per share a year ago.

SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its fourth quarter and full year 2024 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Fourth Quarter 2024 Financial Highlights Net revenues were $151.8 million, an increase of 4.8% year over yea.

Beyond analysts' top -and-bottom-line estimates for Figs (FIGS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.

SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced that Trina Spear, Chief Executive Officer and Co-Founder, and Sarah Oughtred, Chief Financial Officer, are scheduled to participate in a fireside chat at the Raymond James 46th Annual Institutional Investors Conference on Monday, March 3, 2025, at 11:00 a.m. ET. The audio portion of the fireside chat will be web.

SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its fourth quarter and full year 2024 financial results on Thursday, February 27, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a f.

Figs said on Thursday it has rebuffed private equity firm Story3 Capital Partners' offer to acquire the scrubs maker.

SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its third quarter 2024 financial results on Thursday, November 7, 2024, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a third quarter 202.